Cancer in immunosuppressed experimental animals and human patients.
D000818:Animals; D000917:Antibody Formation; D000961:Antilymphocyte Serum; D003601:Cytotoxicity Tests, Immunologic; D017988:Gammaretrovirus; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation; D009052:Leukemia Virus, Murine; D007942:Leukemia, Experimental / Q000209:etiology; D008223:Lymphoma / Q000209:etiology; D051379:Mice; D008808:Mice, Inbred CBA; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology; D009374:Neoplasms, Experimental / Q000209:etiology / Q000276:immunology; D011120:Polyomavirus; D013539:Simian virus 40; D013601:T-Lymphocytes / Q000276:immunology; D013934:Thymectomy; D014184:Transplantation, Homologous; D014777:Virus Diseases / Q000150:complications
D000961:Antilymphocyte Serum